SENIOR JOURNAL.COM - Senior Citizens Information and News

Front Page    Search     Contact Us     Advertise in Senior Journal


SeniorJournal.com

INDEX


FRONT PAGE

PAGE TWO
More Headlines

 • General Features

 • Find Help

 • SENIOR ALERTS

 • Baby Boomers

 • Odds & Ends

Health-Fitness

 • Aging

 • Alzheimer's & Dementia

 • Fitness

 • Health/Medicine

 • Medical Research

 • Nutrition/Vitamin

Government

 • Politics

 • Medicare

 • Medicare Drug Program

 • Medicare Q&A - Dear Marci

 • Medicaid

 • Social Security

 • Social Security, Medicare Q&A

 • Social Security Reform

Enjoying Life

 • Books

 • Entertainment

 • Features

 • Grandparents

 • Senior Statistics

 • Senior Stars

 • Sex & Seniors

 • Sports

 • Travel

 • Senior Volunteers

On The Web

 • Links - Senior

 • Senior Friendly Business Links

 • Sites We Like

Elderly Issues

 • Elder Care

 • Assistance for Elderly

 • Housing

Money 

 • Discounts

 • Guarding Your Wealth for Seniors

 • Money Matters

 • Reverse Mortgage

 • Retirement

Thinking

 • Opinions



Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

• Go to more on Alzheimer's & Dementia or More Senior News on the Front Page

 

Click here to vitamins without a pill.


 
 

E-mail this page to a friend!

Blood Pressure Lowering Drugs Linked To Reduced Risk of Alzheimer's

Diuretics most effective in lowering incidence of Alzheimer's in senior citizens

March 17, 2006 - Taking medications to lower blood pressure, particularly those known as diuretics, may be associated with a lower incidence of Alzheimer's disease, according to a study of senior citizens. Beta blockers and anti-hypertensives also were linked to a slightly protective effect against AD, but ACE inhibitors did not.

 

Related Stories

 
 

Graphic Shows 3-D Structure of Alzheimer's Brain as It Zips Up Peptides

March 8, 2006 – Last November, researchers announced the creation of a unique three-dimensional structure of the long thread-like fibers that fill the brains of Alzheimer's disease patients. This dynamic graphic was published in the February 2006 issue of Inside Salk. Read more and see 3-D image...

Researchers Find Natural Defense to Fight Alzheimer's Disease

Feb. 16, 2006 – Canadian scientist say they have made a significant discovery that could be an important step towards a new therapeutic approach to Alzheimer's disease. They have demonstrated that bone marrow-derived microglia infiltrate amyloid plaques that cause AD and succeed in destroying them "most efficiently" in mice. Read more...

Alzheimer's Disease Neuroimaging Study Seeks Older Volunteers

Nationwide study by the National Institutes of Health needs 800 seniors

Feb. 10, 2006 - The Alzheimer’s Disease Neuroimaging Initiative (ADNI) -- a project developed by the National Institutes of Health (NIH) -- is seeking 800 older adults to participate in a study aimed at identifying biological markers of memory decline and Alzheimer’s disease (AD). Ultimately, scientists hope that brain and biological changes can be detected before memory decline and other symptoms appear, allowing the effectiveness of drugs to be evaluated at the earliest possible time. Read more...

Read more on Alzheimer's & Dementia

 

The study will appear in the May 2006 print issue of the Archives of Neurology, one of the JAMA/Archives journals and was posted online this week.

Hypertension (high blood pressure) may increase the risk of Alzheimer's disease (AD), according to background information in the article. Researchers have therefore begun to examine whether antihypertensive agents, medications prescribed to treat high blood pressure, could reduce the risk of AD.

These drugs include diuretics, which cause the kidneys to excrete water and salt, and beta blockers, which results in slowing the heart rate, reducing the heart's pumping action and widening blood vessels.

Ara S. Khachaturian, Ph.D., of Khachaturian and Associates, Inc., Potomac, Md., and colleagues examined the association between antihypertensive medications and the incidence of AD in 3,297 elderly residents of Cache County, Utah. Between 1995 and 1997, participants age 65 years and older were given an initial interview and assessment that included screening for dementia and a detailed inventory of all prescription and over-the-counter medications.

Residents who had AD at the first interview were not included in the study. Follow-up assessments were done three years later, beginning in 1998.

Of the participants, 1,507 (944 women and 563 men) used antihypertensive medications and 1,790 (975 women, 815 men) did not.

At the second assessment, 104 participants had developed AD.

Elderly individuals who were using antihypertensive medications at the beginning of the study were significantly less likely to have developed AD than those who were not.

This relationship persisted when the researchers controlled for other factors, including gender, age, high cholesterol, diabetes and genetic risk. When antihypertensives were broken down by type, diuretics were most strongly associated with a lower incidence of AD.

More specifically, potassium-sparing diuretics, which contain additional components to preserve levels of the mineral in the body, were related to a more than 70 percent reduction in the risk of AD.

Beta blockers and antihypertensives known as dihydropyridine agents also were linked to a slightly protective effect against AD, while those called ACE inhibitors did not appear to be associated with the risk of developing the condition.

Although the exact reasons for the link between potassium-sparing diuretics and reduced risk of AD is unclear, the authors suggest that the increased blood potassium levels associated with the medications may be a factor. "As yet unpublished findings ...also suggest that increased potassium levels may be associated with a reduced risk of dementia," they write.

"Consistent with this idea are observations that low potassium concentrations are associated with oxidative stress, inflammation, platelet aggregation and vasoconstriction, all of which are possible contributors to AD pathogenesis."

"We suggest these findings should prompt further epidemiologic and basic science studies into the possible neuroprotective effects of these drugs," they conclude.

 

 

 

Click here to Search SeniorJournal.com for more on this subject

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

     Back to Top

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, www.DeweySquare.com, SASeniors.com, DrugDanger.com, etc.

E-mail - editor@SeniorJournal.com